Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives $22.60 Consensus Target Price from Analysts

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month […]

Related Keywords

United States ,Stifel Nicolaus ,Matthewl Sherman ,Deerfield Management Companylp Series ,Deciphera Pharmaceuticals Stock Performance ,Panagora Asset Management Inc ,News Ratings For Deciphera Pharmaceuticals Daily ,Nasdaq ,Deciphera Pharmaceuticals Company Profile ,Insider Transactions At Deciphera Pharmaceuticals ,Jpmorgan Chase Co ,Institutional Investors Weigh In On Deciphera Pharmaceuticals ,Deciphera Pharmaceuticals Inc ,Analyst Recommendations For Deciphera Pharmaceuticals ,Deciphera Pharmaceuticals ,Mirae Asset Global Investments Co ,Deutsche Bank ,Get Free Report ,Asset Global Investments ,Asset Management ,Dark Forest Capital Management ,Forest Capital Management ,Get Free ,Deciphera Pharmaceuticals Daily ,